Counts and Prevalence of Alendronate, Risedronate, Ibandronate, and Zolendronate

Project Title Counts and Prevalence of Alendronate, Risedronate, Ibandronate, and Zolendronate
Date Posted
Monday, March 19, 2018
Project ID
TO16_CAP_STR_WP001-002_NSDP_V01
Status
Complete
Deliverables
Mini-Sentinel Summary Table Report: Counts and Prevalence of Alendronate, Risedronate, Ibandronate, and Zolendronate Report 1
Mini-Sentinel Summary Table Report: Counts and Prevalence of Alendronate, Risedronate, Ibandronate, and Zolendronate Report 2
Description

These reports investigate counts and prevalent use of drug products and procedures in the Mini-Sentinel Distributed Database (MSDD). Report 1 includes prevalence of 11 drug products and Report 2 includes counts and prevalence of 11 Healthcare Common Procedure Coding System (HCPCS) procedure codes. Results were generated using the Mini-Sentinel Distributed Query Tool. Queries were run against the Dispensing Summary Table and distributed on October 30, 2014 to 14 Data Partners; this report includes information from 14 Data Partners.
Medical Product
alendronate sodium
alendronate sodium/vitamin d3
bandronate sodium
calcitonin salmon
calcitonin, salmon, synthetic
denosumab
ibandronate sodium
raloxifene HCL
risedronate sodium
risedronate sodium/calcium carbonate
teriparatide
zoledronic acid
zoledronic acid reclast
zoledronic acid/mannitol and water
zoledroniccid reclast
zoledroniccid zometa
Population / Cohort
All individuals
Time Period
2006-2014
Assessment Type
Exploratory Analyses
Study Type
Summary Table
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER